Detalles de la búsqueda
1.
Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Management of Dyslipidemia and Prevention of Cardiovascular Disease Algorithm - 2020 Executive Summary.
Endocr Pract
; 26(10): 1196-1224, 2020 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-33471721
2.
DYSGLYCEMIA-BASED CHRONIC DISEASE: AN AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS POSITION STATEMENT.
Endocr Pract
; 24(11): 995-1011, 2018 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-30763128
3.
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY 2018 POSITION STATEMENT ON INTEGRATION OF INSULIN PUMPS AND CONTINUOUS GLUCOSE MONITORING IN PATIENTS WITH DIABETES MELLITUS.
Endocr Pract
; 24(3): 302-308, 2018 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-29547046
4.
AACE/ACE POSITION STATEMENT ON THE USE OF FOLLOW-ON BIOLOGICS AND BIOSIMILARS FOR ENDOCRINE DISEASES.
Endocr Pract
; 23(11): 1345-1349, 2017 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-29190135
5.
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF DYSLIPIDEMIA AND PREVENTION OF CARDIOVASCULAR DISEASE.
Endocr Pract
; 23(Suppl 2): 1-87, 2017 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-28437620
6.
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF DYSLIPIDEMIA AND PREVENTION OF CARDIOVASCULAR DISEASE - EXECUTIVE SUMMARYComplete Appendix to Guidelines available at http://journals.aace.com.
Endocr Pract
; 23(4): 479-497, 2017 Apr 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-28156151
7.
A Plethora of GLP-1 Agonists: Decisions About What to Use and When.
Curr Diab Rep
; 16(12): 120, 2016 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-27766579
8.
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY COMPREHENSIVE CLINICAL PRACTICE GUIDELINES FOR MEDICAL CARE OF PATIENTS WITH OBESITY.
Endocr Pract
; 22 Suppl 3: 1-203, 2016 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-27219496
9.
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY COMPREHENSIVE CLINICAL PRACTICE GUIDELINES FOR MEDICAL CARE OF PATIENTS WITH OBESITYEXECUTIVE SUMMARYComplete Guidelines available at https://www.aace.com/publications/guidelines.
Endocr Pract
; 22(7): 842-84, 2016 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-27472012
10.
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY POSITION STATEMENT ON THE ASSOCIATION OF SGLT-2 INHIBITORS AND DIABETIC KETOACIDOSIS.
Endocr Pract
; 22(6): 753-62, 2016 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-27082665
11.
ANTI-OBESITY PHARMACOTHERAPY AND THE POTENTIAL FOR PREVENTING PROGRESSION FROM PREDIABETES TO TYPE 2 DIABETES.
Endocr Pract
; 21(6): 634-44, 2015 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-25716632
12.
Proceedings from the American Association of Clinical Endocrinologists and American College of Endocrinology consensus conference on glucose monitoring.
Endocr Pract
; 21(5): 522-33, 2015 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-25962091
13.
CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM--2015 EXECUTIVE SUMMARY.
Endocr Pract
; 21(12): 1403-14, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26642101
14.
CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM - 2020 EXECUTIVE SUMMARY.
Endocr Pract
; 26(1): 107-139, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32022600
15.
LETTER TO THE EDITOR.
Endocr Pract
; 25(6): 623, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-31242123
16.
American Association of Clinical Endocrinologists and American College of Endocrinology Protocol for Standardized Production of Clinical Practice Guidelines, Algorithms, and Checklists--2014 Update and the AACe G4G Program.
Endocr Pract
; 20(7): 692-702, 2014 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-25057098
17.
American association of clinical endocrinologists and american college of endocrinology consensus conference on obesity: building an evidence base for comprehensive action.
Endocr Pract
; 20(9): 956-76, 2014 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-25253226
18.
CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM - 2019 EXECUTIVE SUMMARY.
Endocr Pract
; 25(1): 69-100, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30742570
19.
Clinical and angiographic risk stratification and differential impact on treatment outcomes in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial.
Circulation
; 126(17): 2115-24, 2012 Oct 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-23008442
20.
Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 2 diabetes (BEGIN Basal-Bolus Type 2): a phase 3, randomised, open-label, treat-to-target non-inferiority trial.
Lancet
; 379(9825): 1498-507, 2012 Apr 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-22521072